TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a novel bioactive coating aimed at improving the interaction between titanium orthopedic implants and bone tissue. This coating incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide production. Laboratory experiments demonstrated that human mesenchymal stem cells exhibited significantly higher survival rates on coated surfaces compared to uncoated titanium. The team analyzed the coating’s structure, chemistry, mechanical features, and biological responses. Their peer-reviewed results appeared in Applied Surface Science in 2026.
Researchers at Tomsk Polytechnic University generated the experimental coatings via reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. During deposition, they adjusted the nitrogen and argon gas mixture to observe how each variation influenced the resulting surface. The study tested five different conditions, from pure nitrogen to pure argon. They then measured several parameters, including coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests assessed how living human cells reacted to the modified titanium surfaces.
Findings revealed that the argon content impacted multiple physical characteristics of the coatings. Surfaces produced in pure argon proved to be denser and harder than those deposited with pure nitrogen. An increase in argon proportion also resulted in thicker coatings. Chemical analysis identified the presence of nitrogen-carbon and nitrogen-oxygen bonds on the treated surfaces. The team compared the biological response of human mesenchymal stem cells grown on coated titanium versus uncoated titanium. The biological tests focused on cell viability and markers related to bone cell development.
Enhanced Cell Survival Observed in Coating Tests
The experiments indicated that cell survival was considerably improved on coated surfaces compared to uncoated titanium, according to the published results. After seven days, coatings with higher nitrogen levels also appeared to suppress activity in certain genes associated with early bone-cell differentiation. Despite this, the cells maintained their ability to form bone tissue. These assessments were conducted under controlled laboratory conditions using human mesenchymal stem cells. It’s important to note that the study did not involve testing the coating on patients or evaluating clinical performance of implanted devices.
The biomedical evaluation was carried out by Immanuel Kant Baltic Federal University and Siberian State Medical University. Additional contributions came from Saint Petersburg State University. The project received funding through Russia’s national science program. Researchers aimed to identify gas mixtures capable of producing optimal combinations of physical, chemical, and biological properties in the coating. Hydroxyapatite is already utilized in implant coatings because its calcium phosphate structure resembles the mineral component in human bone.
Current Research Remains at the Laboratory Stage
The team has outlined plans for further testing beyond the initial seven-day cell study. They intend to observe stem cell behavior over periods ranging from 10 to 28 days. The researchers also plan to investigate the rate at which the coatings dissolve and to measure nitric oxide release into surrounding tissue in living organisms. These additional experiments were not part of the published laboratory findings. The current research focuses on coated titanium substrates, their physical and chemical properties, and in vitro cellular responses, rather than clinical outcomes in orthopaedic patients.
The results provide detailed laboratory data on how varying ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. Differences were documented in coating thickness, density, hardness, chemical bonds, and cellular responses across the different gas mixtures. The study also confirmed that coated samples supported higher stem-cell survival than uncoated titanium under laboratory conditions. However, these findings are preliminary and do not establish safety or efficacy in humans. Further biological testing will be necessary to evaluate properties not examined in the current study.